During infection, flavivirus core proteins migrate to the nucleus of host cells to aid viral replication. Researchers have identified a transporter protein, called importin-7 (IPO7), as crucial for ...

Researchers have identified IPO7 as a carrier of flavivirus core protein into host cell nucleus, paving the way for a new therapeutic approach to a range of diseases.

Scientists now have a way to target a number of insect-borne diseases, including dengue, West Nile, yellow fever and St. Louis encephalitis. Researchers from Purdue University and the California ...

La Jolla Institute for Immunology professor Sujan Shresta, Ph.D. will receive more than $2.4 million from the National Institute of Allergy and Infectious Diseases to help test experimental ...

Study: A volatile from the skin microbiota of flavivirus-infected hosts promotes mosquito attractiveness. Image Credit: urfin/Shutterstock Background Various studies have shown that hosts infected ...

Whether existing antibodies to dengue could enhance infection by another flavivirus, Zika, in humans remains an open question. However, researchers from the Icahn School of Medicine at Mount Sinai in ...

Better designed vaccines for insect-spread viruses like dengue and Zika are likely after researchers discovered models of immature flavivirus particles were originally misinterpreted.

Utilizing ns3 in flavivirus vaccine and drug development. “Most vaccines are developed by finding random mutations that slow down virus growth,” explained senior author Brian Geiss. “By understanding ...

It’s the most zoomed-in image that scientists have gotten of any flavivirus, the family of viruses that includes Zika, dengue, yellow fever, West Nile and Japanese encephalitis viruses, among ...

In recent years, numerous molecular techniques utilizing a generic approach have been described for flavivirus diagnosis. [114–129] For identification of flaviviruses, molecular amplification ...